NexImmune, Inc.
NEXI
$0.0001
$0.000.00%
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 3.43% | -20.62% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.00% | 74.86% | |||
| Operating Income | 1.00% | -74.86% | |||
| Income Before Tax | 24.39% | 42.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 24.39% | 42.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 24.39% | 42.57% | |||
| EBIT | 1.00% | -74.86% | |||
| EBITDA | -0.45% | -95.97% | |||
| EPS Basic | 31.50% | 51.15% | |||
| Normalized Basic EPS | 55.88% | -84.12% | |||
| EPS Diluted | 31.50% | 51.15% | |||
| Normalized Diluted EPS | 55.88% | -84.12% | |||
| Average Basic Shares Outstanding | 10.39% | 17.56% | |||
| Average Diluted Shares Outstanding | 10.39% | 17.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
